Document Type : Original Research Article
Authors
- Jorge Cea García 1
- M. Carmen Rubio Rodríguez 2
- Francisco Márquez Maraver 1
- Laura Ríos-Pena 3
- Inmaculada Rodríguez Jiménez 1
1 Clinical Management Unit for Obstetrics and Gynecology, University Hospital Virgen Macarena, Seville, Spain
2 Department of Radiation Oncology, HM Hospitals, University Hospital Sanchinarro, Madrid, Spain
3 Institute of Science and Technology, Loyola University, Dos Hermanas, Seville, Spain
Abstract
Background & Objective: Sexual dysfunction is the symptom with the greatest negative impact on the quality of life of cervical cancer survivors. However, the evaluation of sexual function is challenging, and there is ongoing debate concerning its determinants. We aimed to identify predictive variables for sexual function after cervical cancer treatment.
Materials & Methods: One hundred and four cervical cancer survivors participated in a prospective cohort study that we carried out employing FACT–Cx v.4.0 and FSFI questionnaires.
Results: We developed a beta generalized linear model with a predictive accuracy of 78% (C–index=0.78) and based on vaginal shortening (Cx4) (P=0.077), age (P=0.0002), and ovarian preservation (P=0.01) as risk factors, and functional well–being (P<0.0001) and follow–up duration (P=0.015) as protective factors.
Conclusion: To the best of our knowledge, we may have created the first reliable and internally validated prediction model for cervical cancer survivors based on predictors like vaginal shortening, age, ovarian preservation, functional well–being, and follow–up duration that significantly affect female sexual function as targets for potential intervention.
Keywords
Main Subjects
1. Hayes R, Dennerstein L. The Impact of Aging on Sexual Function and Sexual Dysfunction in Women: A Review of Population‐Based Studies. J Sex Med. 2005;2(3):317-30. [DOI:10.1111/j.1743-6109.2005.20356.x] [PMID]
2. Park SY, Bae D-S, Nam JH, Park CT, Cho C-H, Lee JM, et al. Quality of life and sexual problems in disease-free survivors of cervical cancer compared with the general population. Cancer. 2007;110(12):2716-25. [DOI:10.1002/cncr.23094] [PMID]
3. Zhou W, Yang X, Dai Y, Wu Q, He G, Yin G. Survey of cervical cancer survivors regarding quality of life and sexual function. J Cancer Res Ther. 2016;12(2):938-44. [DOI:10.4103/0973-1482.175427] [PMID]
4. Covens A, Rosen B, Murphy J, Laframboise S, DePetrillo AD, Lickrish G, et al. Changes in the Demographics and Perioperative Care of Stage IA2/IB1 Cervical Cancer over the Past 16 Years. Gynecol Oncol. 2001;81(2):133-7. [DOI:10.1006/gyno.2001.6158] [PMID]
5. Jensen PT, Groenvold M, Klee MC, Thranov I, Petersen MA, Machin D. Early-stage cervical carcinoma, radical hysterectomy, and sexual function. Cancer. 2004;100(1):97-106. [DOI:10.1002/cncr.11877] [PMID]
6. Bjelic-Radisic V, Jensen PT, Vlasic KK, Waldenstrom A-C, Singer S, Chie W, et al. Quality of life characteristics inpatients with cervical cancer. Eur J Cancer. 2012;48(16):3009-18. [DOI:10.1016/j.ejca.2012.05.011] [PMID]
7. Fadhilla HN, Mudigdo A, Rahardjo SS. Effect of age and socio economic status on the quality of life of patients with cervical cancer undertaking chemotherapy at Dr. Moewardi Hospital Surakarta. J Epidemiol Pub Health. 2017;2(1):11-9. [DOI:10.26911/jepublichealth.2017.02.01.02]
8. Korfage IJ, Essink-Bot ML, Mols F, van de Poll-Franse L, Kruitwagen R, van Ballegooijen M. Health-related quality of life in cervical cancer survivors: a population-based survey. Int J Radiat Oncol Biol Phys. 2009;73(5):1501-9. [DOI:10.1016/j.ijrobp.2008.06.1905] [PMID]
9. Carter J, Sonoda Y, Baser RE, Raviv L, Chi DS, Barakat RR, et al. A 2-year prospective study assessing the emotional, sexual, and quality of life concerns of women undergoing radical trachelectomy versus radical hysterectomy for treatment of early-stage cervical cancer. Gynecol Oncol. 2010;119(2):358-65. [DOI:10.1016/j.ygyno.2010.07.016] [PMID] [PMCID]
10. Liu H, Yu J, Chen Y, He P, Zhou L, Tang X, et al. Sexual function in cervical cancer patients: Psychometric properties and performance of a Chinese version of the Female Sexual Function Index. Eur J Oncol Nurs. 2016;20:24-30. [DOI:10.1016/j.ejon.2015.06.007] [PMID]
11. Pauls RN, Kleeman SD, Segal JL, Silva WA, Goldenhar LM, Karram MM. Practice patterns of physician members of the American Urogynecologic Society regarding female sexual dysfunction: results of a national survey. Int Urogynecol J. 2005;16:460-7. [DOI:10.1007/s00192-005-1286-5] [PMID]
12. Safarinejad MR. Female sexual dysfunction in a population-based study in Iran: prevalence and associated risk factors. Int J Impot Res. 2006;18(4):382-95. [DOI:10.1038/sj.ijir.3901440] [PMID]
13. Thiel RdRC, Dambros M, Palma PCR, Thiel M, Riccetto CLZ, Ramos MdF. Tradução para português, adaptação cultural e validação do Female Sexual Function Index. Rev Bras Ginecol Obstet. 2008;30:504-10. [DOI:10.1590/S0100-72032008001000005] [PMID]
14. Laumann EO, Glasser DB, Neves RCS, Moreira ED. A population-based survey of sexual activity, sexual problems and associated help-seeking behavior patterns in mature adults in the United States of America. Int J Impot Res. 2009;21(3):171-8. [DOI:10.1038/ijir.2009.7] [PMID]
15. Serati M, Salvatore S, Uccella S, Laterza RM, Cromi A, Ghezzi F, Bolis P. Sexual Function After Radical Hysterectomy for Early-Stage Cervical Cancer: Is There a Difference between Laparoscopy and Laparotomy?. J Sex Med. 2009;6(9):2516-22. [DOI:10.1111/j.1743-6109.2009.01363.x] [PMID]
16. Ratner ES, Foran KA, Schwartz PE, Minkin MJ. Sexuality and intimacy after gynecological cancer. Maturitas. 2010;66(1):23-6. [DOI:10.1016/j.maturitas.2010.01.015] [PMID]
17. Marcello C, Giovanni R, Emanuela S, Paolo C, Roberto C, Michele P, et al. Pelvic Dysfunctions and Quality of Life after Nerve-sparing Radical Hysterectomy: A Multicenter Comparative Study. Anticancer Res. 2012;32(2):581-8.
18. Afiyanti Y, Milanti A. Physical sexual and intimate relationship concerns among Indonesian cervical cancer survivors: A phenomenological study. Nurs Health Sci. 2013;15(2):151-6. [DOI:10.1111/nhs.12006] [PMID]
19. Briedite I, Ancane G, Ancans A, Erts R. Insufficient Assessment of Sexual Dysfunction: A Problem in Gynecological Practice. Medicina. 2013;49(7):315-20. [DOI:10.3390/medicina49070049]
20. Stead ML, Fallowfield L, Selby P, Brown JM. Psychosexual function and impact of gynaecological cancer. Best Pract Res Clin Obstet Gynaecol. 2007;21(2):309-20. [DOI:10.1016/j.bpobgyn.2006.11.008] [PMID]
21. Distefano M, Riccardi S, Capelli G, Costantini B, Petrillo M, Ricci C, et al. Quality of life and psychological distress in locally advanced cervical cancer patients administered pre-operative chemoradiotherapy. Gynecol Oncol. 2008;111(1):144-50. [DOI:10.1016/j.ygyno.2008.06.034] [PMID]
22. Lau K-L, Yim PH-W, Cheung EY-W. Psychiatric morbidity in Chinese women after cervical cancer treatment in a regional gynaecology clinic. East Asian Arch Psychiatry. 2013;23(4):144-53.
23. Tsatsou I, Parpa E, Tsilika E, Katsaragakis S, Batistaki C, Dimitriadou E, et al. A Systematic Review of Sexuality and Depression of Cervical Cancer Patients. J Sex Marital Ther. 2019;45(8):739-54. [DOI:10.1080/0092623X.2019.1610125] [PMID]
24. Valadares AL, Pinto-Neto AM, Conde DM, Sousa MH, Osis MJ, Costa-Paiva L. A population-based study of dyspareunia in a cohort of middle-aged Brazilian women. Menopause. 2008;15(6):1184-90. [DOI:10.1097/gme.0b013e31817062bc] [PMID]
25. Carter J, Penson R, Barakat R, Wenzel L. Contemporary quality of life issues affecting gynecologic cancer survivors. Hematol Oncol Clin. 2012;26(1):169-94. [DOI:10.1016/j.hoc.2011.11.001] [PMID] [PMCID]
26. Derks M, van Lonkhuijzen LR, Bakker RM, Stiggelbout AM, de Kroon CD, Westerveld H, et al. Long-Term Morbidity and Quality of Life in Cervical Cancer Survivors: A Multicenter Comparison Between Surgery and Radiotherapy as Primary Treatment. Int J Gynecol Cancer. 2017;27(2):350-6. [DOI:10.1097/IGC.0000000000000880] [PMID]
27. Marino JL, Saunders CM, Emery LI, Green H, Doherty DA, Hickey M. Nature and severity of menopausal symptoms and their impact on quality of life and sexual function in cancer survivors compared with women without a cancer history. Menopause. 2014;21(3):267-74. [DOI:10.1097/GME.0b013e3182976f46] [PMID]
28. Lee Y, Lim MC, Kim SI, Joo J, Lee DO, Park SY. Comparison of Quality of Life and Sexuality between Cervical Cancer Survivors and Healthy Women. Cancer Res Treat. 2016;48(4):1321-9. [DOI:10.4143/crt.2015.425] [PMID] [PMCID]
29. Burns M, Costello J, Ryan-Woolley B, Davidson S. Assessing the impact of late treatment effects in cervical cancer: an exploratory study of women's sexuality. Eur J Cancer Care. 2007;16(4):364-72. [DOI:10.1111/j.1365-2354.2006.00743.x] [PMID]
30. Huffman LB, Hartenbach EM, Carter J, Rash JK, Kushner DM. Maintaining sexual health throughout gynecologic cancer survivorship: A comprehensive review and clinical guide. Gynecol Oncol. 2016;140(2):359-68. [DOI:10.1016/j.ygyno.2015.11.010] [PMID] [PMCID]
31. Stolldorf DP, Dietrich MS, Ridner SH. Symptom frequency, intensity, and distress in patients with lower limb lymphedema. Lymphat Res Biol. 2016;14(2):78-87. [DOI:10.1089/lrb.2015.0027] [PMID] [PMCID]
32. Yip S-K, Cardozo L. Psychological morbidity and female urinary incontinence. Best Pract Res Clin Obstet Gynaecol. 2007;21(2):321-9. [DOI:10.1016/j.bpobgyn.2006.12.002] [PMID]
33. Coyne KS, Sexton CC, Irwin DE, Kopp ZS, Kelleher CJ, Milsom I. The impact of overactive bladder, incontinence and other lower urinary tract symptoms on quality of life, work productivity, sexuality and emotional well-being in men and women: results from the EPIC study. BJU Int. 2008;101(11):1388-95. [DOI:10.1111/j.1464-410X.2008.07601.x] [PMID]
34. Egil Skjeldestad F, Hagen B. Long-term consequences of gynecological cancer treatment on urinary incontinence: a population-based cross-sectional study. Acta Obstet Gynecol Scand. 2008;87(4):469-75. [DOI:10.1080/00016340801948326] [PMID]
35. Ratner ES, Erekson EA, Minkin MJ, Foran-Tuller KA. Sexual satisfaction in the elderly female population: A special focus on women with gynecologic pathology. Maturitas. 2011;70(3):210-5. [DOI:10.1016/j.maturitas.2011.07.015] [PMID] [PMCID]
36. Abbott-Anderson K, Kwekkeboom KL. A systematic review of sexual concerns reported by gynecological cancer survivors. Gynecol Oncol. 2012;124(3):477-89. [DOI:10.1016/j.ygyno.2011.11.030] [PMID]
37. Jensen PT, Groenvold M, Klee MC, Thranov I, Petersen MA, Machin D. Longitudinal study of sexual function and vaginal changes after radiotherapy for cervical cancer. Int J Radiat Oncol Biol Phys. 2003;56(4):937-49. [DOI:10.1016/S0360-3016(03)00362-6] [PMID]
38. Juraskova I, Butow P, Robertson R, Sharpe L, McLeod C, Hacker N. Post-treatment sexual adjustment following cervical and endometrial cancer: a qualitative insight. Psychooncology. 2003;12(3):267-79. [DOI:10.1002/pon.639] [PMID]
39. Song T, Choi CH, Lee Y-Y, Kim T-J, Lee J-W, Kim B-G, et al. Sexual Function After Surgery for Early-Stage Cervical Cancer: Is There a Difference in it According to the Extent of Surgical Radicality?. J Sex Med. 2012;9(6):1697-704. [DOI:10.1111/j.1743-6109.2012.02723.x] [PMID]
40. Shin DW, Nam JH, Kwon YC, Park SY, Bae D-S, Park CT, et al. Comorbidity in Disease-Free Survivors of Cervical Cancer Compared with the General Female Population. Oncology. 2008;74(3-4):207-15. [DOI:10.1159/000151368] [PMID]
41. Hung M-C, Wu C-L, Hsu Y-Y, Hwang J-S, Cheng Y-M, Wang J-D. Estimation of potential gain in quality of life from early detection of cervical cancer. Value Health. 2014;17(4):482-6. [DOI:10.1016/j.jval.2014.02.006] [PMID]
42. Wang X, Chen C, Liu P, Li W, Wang L, Liu Y. The morbidity of sexual dysfunction of 125 Chinese women following different types of radical hysterectomy for gynaecological malignancies. Arch Gynecol Obstet. 2018;297:459-66. [DOI:10.1007/s00404-017-4625-0] [PMID]
43. Shu-Qin C, Ling-Zhi K, Hong-Ye J, Li F, Jun C, Shu-Zhong Y. Early Cervical Cancer Impact of Peritoneal Vaginoplasty Combined With Laparoscopic Radical Hysterectomy Improved Sexual Function. Int J Gynecol Cancer. 2015;25(3):526-32. [DOI:10.1097/IGC.0000000000000366] [PMID]
44. Vaz AF, Pinto-Neto AM, Conde DM, Costa-Paiva L, Morais SS, Pedro AO, et al. Quality of life and menopausal and sexual symptoms in gynecologic cancer survivors: a cohort study. Menopause. 2011;18(6):662-9. [DOI:10.1097/gme.0b013e3181ffde7f] [PMID]
45. Hofsjö A, Bergmark K, Blomgren B, Jahren H, Bohm-Starke N. Radiotherapy for cervical cancer - impact on the vaginal epithelium and sexual function. Acta Oncol. 2018;57(3):338-45. [DOI:10.1080/0284186X.2017.1400684] [PMID]
46. Singh R, Chopra S, Engineer R, Paul S, Kannan S, Mohanty S, et al. Dose-volume correlation of cumulative vaginal doses and late toxicity after adjuvant external radiation and brachytherapy for cervical cancer. Brachytherapy. 2017;16(4):855-61. [DOI:10.1016/j.brachy.2017.03.008] [PMID]
47. Mohanty SK, Chopra S, Mudaliar A, Kannan S, Mahantshetty U, Engineer R, et al. A comparative analysis of quality of life after postoperative intensity-modulated radiotherapy or three-dimensional conformal radiotherapy for cervical cancer. Indian J Cancer. 2018;55(4):327-35. [DOI:10.4103/ijc.IJC_453_17] [PMID]
48. Yavas G, Yavas C, Dogan NU, Ilhan TT, Dogan S, Karabagli P, et al. Pelvic radiotherapy does not deteriorate the quality of life of women with gynecologic cancers in long-term follow-up: A 2 years prospective single-center study. J Cancer Res Ther. 2017;13(3):524-32.
49. Baser RE, Li Y, Carter J. Psychometric validation of the female sexual function index (FSFI) in cancer survivors. Cancer. 2012;118(18):4606-18. [DOI:10.1002/cncr.26739] [PMID]
50. Stephenson KR, Toorabally N, Lyons L, M. Meston C. Further Validation of the Female Sexual Function Index: Specificity and Associations With Clinical Interview Data. J Sex Marital Ther. 2016;42(5):448-61. [DOI:10.1080/0092623X.2015.1061078] [PMID]
51. Castillo-Ávila IY, Canencia-Padilla J, Zurbarán-Lamadrid M, Pertuz-Cantillo D, Montes-Padilla M, Jiménez-Chacón E. Quality of life in women with cervical cancer, Cartagena (Colombia), 2012. Revista Colomb de Obstet y Ginec. 2015;66(1):22-31. [DOI:10.18597/rcog.4]
52. Cella D, Hernandez L, Bonomi AE, Corona M, Vaquero M, Shiomoto G, et al. Spanish language translation and initial validation of the functional assessment of cancer therapy quality-of-life instrument. Med Care. 1998;36(9):1407-18. [DOI:10.1097/00005650-199809000-00012] [PMID]
53. Rosen osen R, Brown C, Heiman J, Leiblum S, Meston C, Shabsigh R, et al. The Female Sexual Function Index (FSFI): A Multidimensional Self-Report Instrument for the Assessment of Female Sexual Function. J Sex Marital Ther. 2000;26(2):191-208. [DOI:10.1080/009262300278597] [PMID]
54. Wiegel M, Meston C, Rosen R. The Female Sexual Function Index (FSFI): Cross-Validation and Development of Clinical Cutoff Scores. J Sex Marital Ther. 2005;31(1):1-20. [DOI:10.1080/00926230590475206] [PMID]
55. Lou Q. Sexual dysfuncion in women with type 2 diabetes in 3A hospitals in Hangzhou. Hangzhou: Med Sch Zhejiang Univ. 2010.
56. Schover LR, Fife M, Gershenson DM. Sexual dysfunction and treatment for early stage cervical cancer. Cancer. 1989;63(1):204-12. [DOI:10.1002/1097-0142(19890101)63:13.0.CO;2-U] [PMID]
57. Hellsten C, Lindqvist PG, Sjöström K. A longitudinal study of sexual functioning in women referred for colposcopy: a 2-year follow up. BJOG: Int J Obstet Gynaecol. 2008;115(2):205-11. [DOI:10.1111/j.1471-0528.2007.01503.x] [DOI:10.1111/j.1471-0528.2007.01609.x] [PMID]
58. Shuang Y, Jiaxin Y, Dongyan C, Jinghe L, Keng S. A Systematic Review of Quality of Life and Sexual Function of Patients With Cervical Cancer After Treatment. Int J Gynecol Cancer. 2014;24(7):1146. [DOI:10.1097/IGC.0000000000000207] [PMID]
59. Bergmark K, Åvall-Lundqvist E, Dickman PW, Henningsohn L, Steineck G. Vaginal changes and sexuality in women with a history of cervical cancer. New Eng J Med. 1999;340(18):1383-9. [DOI:10.1056/NEJM199905063401802] [PMID]
60. Ferrandina G, Mantegna G, Petrillo M, Fuoco G, Venditti L, Terzano S, et al. Quality of life and emotional distress in early stage and locally advanced cervical cancer patients: A prospective, longitudinal study. Gynecol Oncol. 2012;124(3):389-94. [DOI:10.1016/j.ygyno.2011.09.041] [PMID]
61. Signorelli M, Bogani G, Chiappa V, Ditto A, Scaffa C, Martinelli F, et al. Ovarian preservation in locally advanced cervical cancer undergoing neoadjuvant chemotherapy and radical surgery. Minerva Ginecol. 2018;70(4):357-63. [DOI:10.23736/S0026-4784.18.04221-1] [PMID]
62. Li C, Samsioe G, Iosif C. Quality of life in long-term survivors of cervical cancer. Maturitas. 1999;32(2):95-102. [DOI:10.1016/S0378-5122(99)00020-1] [PMID]
)
